Dexcom Continuous Glucose Monitor (CGM)
The Dexcom G6 eliminates fingersticks for calibration, diabetes treatment decisions and diabetes management*
CGM, The Basics: https://youtu.be/u3LH6eRquEw
- The Dexcom G6 CGM System can now be used in place of fingerstick testing for treatment decisions*
- The Dexcom CGM System is permitted for ages 2 years and older on the abdomen and lower back. For 18 and over, the Dexcom CGM is approved for the abdomen
- The Dexcom CGM is compatible with iOS and Android platforms which allow glucose readings on a compatible smart device†
- The Dexcom also has a Share feature which allows you to share your glucose readings with up to five individuals‡. By downloading the Dexcom Follow® app, followers can view your real-time glucose data directly from their smart device giving you the circle of support you need.
Hear from users just like you! Dexcom Warriors
Visit www.Dexcom.com/Dexcom-with-share for more information
Benefits of CGM
Unlike a blood glucose meter (BGM), which provides just a single glucose reading, CGM systems provide real-time, dynamic glucose information every five minutes — up to 288 readings in a 24-hour period. You can gain valuable insight about your glucose levels, speed, and direction giving you additional insight to proactively manage your diabetes.
- A1c Reduction: CGM has proven to be the best outpatient glycemic management system for reducing A1C. Type 1 diabetics have experienced an average A1C reduction of 1.3%**.
- Reduced Hypoglycemia: Not only can CGM reduce A1C, numerous studies have shown it can also decrease time spent in hypoglycemia1-3
- Alerts and Alarms: CGM Systems are equipped with alerts and alarms that notify you of approaching highs and lows
- Real-time glucose information: CGM provides real-time information about your glucose level speed and direction (high or low), so you have more insight for proactively managing your diabetes
*If your glucose alerts and readings from the G6 do not match symptoms or expectations, use a blood glucose meter to make diabetes treatment decisions.
†Click here for a list of compatible smart devices
‡Do not make treatment decisions based on share and follow readings. Always confirm with your compatible smart device or Dexcom receiver.
**MDI patients with baseline A1C ≥ 8.5%
1 Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group. Continuous Glucose Monitoring and Intensive Treatment of Type 1 Diabetes, N Engl J Med. 2008: 359(14); 1464-1476.
2 Soupal J, Petruzelkova L, Flekac M, et al. Comparison of Different Treatment Modalities for Type 1 Diabetes, Including Sensor-Augmented Insulin Regimens, in 52 Weeks of Follow-Up: A COMISAIR Study. Diabetes Technol Ther. 2016;18(9):532-538.
3 Beck RW, Riddlesworth T, Ruedy K, et al. Effect of continuous glucose monitoring on glycemic control in adults with type 1 diabetes using insulin injections: The diamond randomized clinical trial. JAMA. 2017;317(4):371-378. doi:10.1001/jama.2016.19975.